NCT04448132View on ClinicalTrials.gov

Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)

PHASE4CompletedINTERVENTIONAL

Enrollment

163

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

May 3, 2021

Study Completion Date

May 3, 2021

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

IPV-Al

adjuvanted reduced dose inactivated polio vaccine

Trial Locations (1)

Unknown

Cevaxim, Panama City

Sponsors

Lead Sponsor

AJ Vaccines A/S

All Listed Sponsors

lead

AJ Vaccines A/S

INDUSTRY